Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.

Literature DB >> 31267489

Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.

Xiaoyu Dong¹, Jianfei Nao².

Abstract

Entities: Gene Species

Mesh：

Substances：
Biomarkers
Cystatin C

Year: 2019 PMID： 31267489 DOI： 10.1007/s12640-019-00082-2

Source DB: PubMed Journal: Neurotox Res ISSN： 1029-8428 Impact factor: 3.911

Keyword Cloud
References

× No keyword cloud information.

33 in total

Review 1. Biological activities of C1 inhibitor.

Authors: Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal: Mol Immunol Date: 2008-07-31 Impact factor: 4.407

2. Cystatin C expression is increased in the hippocampus following photothrombotic stroke in rat.

Authors: Terhi J Pirttilä; Asla Pitkänen
Journal: Neurosci Lett Date: 2005-11-23 Impact factor: 3.046

3. Factors Associated With Ischemic Stroke Survival and Recovery in Older Adults.

Authors: Divya Thekkethala Winovich; William T Longstreth; Alice M Arnold; Ravi Varadhan; Adina Zeki Al Hazzouri; Mary Cushman; Anne B Newman; Michelle C Odden
Journal: Stroke Date: 2017-05-19 Impact factor: 7.914

4. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.

Authors: Yu Kyung Chung; Young Ju Lee; Kye Whon Kim; Ryu Kyoung Cho; Seung Min Chung; Jun Sung Moon; Ji Sung Yoon; Kyu Chang Won; Hyoung Woo Lee
Journal: Diab Vasc Dis Res Date: 2017-11-01 Impact factor: 3.291

5. Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke.

Authors: Bo Yang; Jiangtao Zhu; Zhigang Miao; Beiqun Zhou; Wei Ge; Heqing Zhao; Xingshun Xu
Journal: Neurotox Res Date: 2015-02-20 Impact factor: 3.911

6. Association Between Serum Cystatin C Level and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients With Acute Lacunar Stroke.

Authors: Song Yang; Jing Cai; Rulan Lu; Jian Wu; Min Zhang; Xianju Zhou
Journal: J Stroke Cerebrovasc Dis Date: 2016-10-07 Impact factor: 2.136

Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.

Review 1. Biological activities of C1 inhibitor.

2. Cystatin C expression is increased in the hippocampus following photothrombotic stroke in rat.

3. Factors Associated With Ischemic Stroke Survival and Recovery in Older Adults.

4. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.

5. Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke.

6. Association Between Serum Cystatin C Level and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients With Acute Lacunar Stroke.

7. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.

8. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project.

9. Association between serum uric acid and carotid disease in patients with atherosclerotic acute ischemic stroke.

10. Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds.